254 related articles for article (PubMed ID: 24992122)
1. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012.
von Mollendorf C; Cohen C; de Gouveia L; Naidoo N; Meiring S; Quan V; Lindani S; Moore DP; Reubenson G; Moshe M; Eley B; Hallbauer UM; Finlayson H; Madhi SA; Conklin L; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
Pediatr Infect Dis J; 2015 Jan; 34(1):27-34. PubMed ID: 24992122
[TBL] [Abstract][Full Text] [Related]
2. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.
von Mollendorf C; von Gottberg A; Tempia S; Meiring S; de Gouveia L; Quan V; Lengana S; Avenant T; du Plessis N; Eley B; Finlayson H; Reubenson G; Moshe M; O'Brien KL; Klugman KP; Whitney CG; Cohen C;
Clin Infect Dis; 2015 May; 60(9):1346-56. PubMed ID: 25645212
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.
von Gottberg A; Cohen C; de Gouveia L; Meiring S; Quan V; Whitelaw A; Crowther-Gibson P; Madhi SA; Whitney CG; Klugman KP
Vaccine; 2013 Aug; 31(38):4200-8. PubMed ID: 23684826
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.
Cohen C; von Mollendorf C; de Gouveia L; Naidoo N; Meiring S; Quan V; Nokeri V; Fortuin-de Smit M; Malope-Kgokong B; Moore D; Reubenson G; Moshe M; Madhi SA; Eley B; Hallbauer U; Kularatne R; Conklin L; O'Brien KL; Zell ER; Klugman K; Whitney CG; von Gottberg A;
Clin Infect Dis; 2014 Sep; 59(6):808-18. PubMed ID: 24917657
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005.
Nyasulu P; Cohen C; De Gouveia L; Feldman C; Klugman KP; von Gottberg A;
Pediatr Infect Dis J; 2011 Dec; 30(12):1075-80. PubMed ID: 21799459
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.
Pilishvili T; Zell ER; Farley MM; Schaffner W; Lynfield R; Nyquist AC; Vazquez M; Bennett NM; Reingold A; Thomas A; Jackson D; Schuchat A; Whitney CG
Pediatrics; 2010 Jul; 126(1):e9-17. PubMed ID: 20547641
[TBL] [Abstract][Full Text] [Related]
7. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV).
Meiring S; Cohen C; Quan V; de Gouveia L; Feldman C; Karstaedt A; Klugman KP; Madhi SA; Rabie H; Sriruttan C; von Gottberg A;
PLoS One; 2016; 11(2):e0149104. PubMed ID: 26863135
[TBL] [Abstract][Full Text] [Related]
8. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.
Madhi SA; Cohen C; von Gottberg A
Vaccine; 2012 Sep; 30 Suppl 3():C21-7. PubMed ID: 22939016
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
[No Abstract] [Full Text] [Related]
10. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
11. Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period.
De Serres G; Pilishvili T; Link-Gelles R; Reingold A; Gershman K; Petit S; Farley MM; Harrison LH; Lynfield R; Bennett NM; Baumbach J; Thomas A; Schaffner W; Beall B; Whitney C; Moore M
Vaccine; 2012 Jun; 30(27):4067-72. PubMed ID: 22525797
[TBL] [Abstract][Full Text] [Related]
12. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.
Harboe ZB; Dalby T; Weinberger DM; Benfield T; Mølbak K; Slotved HC; Suppli CH; Konradsen HB; Valentiner-Branth P
Clin Infect Dis; 2014 Oct; 59(8):1066-73. PubMed ID: 25034421
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.
Harboe ZB; Larsen MV; Ladelund S; Kronborg G; Konradsen HB; Gerstoft J; Larsen CS; Pedersen C; Pedersen G; Obel N; Benfield T
Clin Infect Dis; 2014 Oct; 59(8):1168-76. PubMed ID: 25038114
[TBL] [Abstract][Full Text] [Related]
14. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis.
Nunes MC; von Gottberg A; de Gouveia L; Cohen C; Moore DP; Klugman KP; Madhi SA
AIDS; 2011 Feb; 25(4):453-62. PubMed ID: 21178754
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
[TBL] [Abstract][Full Text] [Related]
16. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease.
Yildirim I; Shea KM; Little BA; Silverio AL; Pelton SI;
Pediatrics; 2015 Mar; 135(3):495-503. PubMed ID: 25647674
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naïve South African children and their mothers.
Nunes MC; Shiri T; van Niekerk N; Cutland CL; Groome MJ; Koen A; von Gottberg A; de Gouveia L; Klugman KP; Adrian PV; Madhi SA
Pediatr Infect Dis J; 2013 May; 32(5):e192-205. PubMed ID: 23340555
[TBL] [Abstract][Full Text] [Related]
18. Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.
Ladhani SN; Andrews NJ; Waight P; Borrow R; Slack MP; Miller E
Clin Infect Dis; 2014 Feb; 58(4):517-25. PubMed ID: 24300040
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes.
Ciruela P; Soldevila N; Hernández S; Selva L; de Sevilla MF; García-García JJ; Moraga F; Planes AM; Muñoz-Almagro C; Domínguez A
Vaccine; 2013 Jan; 31(6):960-6. PubMed ID: 23261046
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]